We are live on ! Find out more
ZNTL icon

Zentalis Pharmaceuticals

61 hedge funds and large institutions have $1.28B invested in Zentalis Pharmaceuticals in 2020 Q2 according to their latest regulatory filings, with 61 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

74.86% more ownership

Funds ownership: 0%74.86% (+75%)

Holders
61
Holders Change
+61
Holders Change %
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
61
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
26
Charles Schwab
California
$3.16M +$2.52M +65,805 New
MWNA
27
Marshall Wace North America
New York
$2.86M +$2.29M +59,629 New
ZP
28
Zimmer Partners
New York
$2.64M +$2.11M +55,000 New
WP
29
Woodline Partners
California
$2.1M +$1.68M +43,726 New
N
30
Nuveen
North Carolina
$1.94M +$1.55M +40,464 New
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.5M +$1.2M +31,162 New
CCM
32
CAAS Capital Management
New York
$1.2M +$959K +25,000 New
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$1.2M +$956K +24,935 New
California Public Employees Retirement System
34
California Public Employees Retirement System
California
$1.1M +$877K +22,859 New
TD Asset Management
35
TD Asset Management
Ontario, Canada
$1.08M +$863K +22,493 New
Bank of America
36
Bank of America
North Carolina
$814K +$650K +16,939 New
State of Wisconsin Investment Board
37
State of Wisconsin Investment Board
Wisconsin
$792K +$633K +16,500 New
California State Teachers Retirement System (CalSTRS)
38
California State Teachers Retirement System (CalSTRS)
California
$748K +$598K +15,587 New
Goldman Sachs
39
Goldman Sachs
New York
$664K +$530K +13,820 New
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$631K +$504K +13,141 New
Jane Street
41
Jane Street
New York
$624K +$498K +12,994 New
MIM
42
MetLife Investment Management
New Jersey
$488K +$389K +10,154 New
Morgan Stanley
43
Morgan Stanley
New York
$486K +$388K +10,125 New
New York State Common Retirement Fund
44
New York State Common Retirement Fund
New York
$456K +$364K +9,500 New
AIG
45
American International Group
New York
$304K +$243K +6,323 New
Manulife (Manufacturers Life Insurance)
46
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$270K +$228K +5,935 New
SG Americas Securities
47
SG Americas Securities
New York
$269K +$215K +5,597 New
CF
48
CNA Financial
Illinois
$261K +$208K +5,426 New
Deutsche Bank
49
Deutsche Bank
Germany
$252K +$201K +5,236 New
Wells Fargo
50
Wells Fargo
California
$252K +$201K +5,245 New

ZNTL Hedge Fund Activity: Q2 2020 in Review

61 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Zentalis Pharmaceuticals (ZNTL) for Q2 2020, worth a combined $1.28B.

Buyers outnumbered sellers: 61 funds opened new ZNTL positions and 0 closed out — a net gain of 61 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Viking Global Investors, opening a new position worth an estimated $170M.

  • 61 institutional investors held Zentalis Pharmaceuticals (ZNTL) as of Q2 2020, up from 0 in Q1 2020.
  • Funds reported $1.28B of Zentalis Pharmaceuticals stock for Q2 2020.
  • 61 funds opened new Zentalis Pharmaceuticals positions in Q2 2020 and 0 closed out, a net change of +61 holders.
  • The largest Zentalis Pharmaceuticals buyer in Q2 2020 was Viking Global Investors, an estimated $170M added.

Based on aggregated 13F filings for Q2 2020.